Clinical Trials Logo
  1. Home
  2. Candidiasis, Vulvovaginal
  3. NCT03975569

Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis

Candidiasis, Vulvovaginal Clinical Trial

Official title:
Studie Van de Vaginale Microbiota en Het Potentieel Van Een Vaginale Zalf Met Probiotica Bij Vaginale Candidose

Clinical Trial Summary

This study evaluated the effect of a vaginal gel containing three live probiotic bacteria on vaginal Candida albicans infection in flemish patients (n=20). The therapeutic effects of the gel will be clinically evaluated (vaginal pH, microscopic and clinical scores). The effect on the vaginal microbiome will be evaluated through 16S ribosomal RNA amplicon sequencing via MiSeq Illumina and polymerase chain reaction (PCR) for Candida albicans.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03975569
Study type Interventional
Source University Hospital, Antwerp
Contact
Status Completed
Phase N/A
Start date April 4, 2016
Completion date March 31, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT02971007 - Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Phase 2
Completed NCT02251093 - Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis Phase 3
Completed NCT01293643 - A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) Phase 3
Not yet recruiting NCT04626258 - Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis Phase 4
Completed NCT02733432 - RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections Phase 2
Completed NCT02248506 - Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis Phase 4
Completed NCT02730494 - Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation Phase 1
Completed NCT02180828 - Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Phase 4
Recruiting NCT04930107 - Vulvovaginal Candidiasis in Canadian Females Early Phase 1
Withdrawn NCT03167957 - Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis Phase 2
Recruiting NCT05367089 - The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms Phase 3
Terminated NCT02859493 - Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis N/A
Completed NCT01891331 - A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) Phase 2
Completed NCT02888197 - Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization N/A
Recruiting NCT05059145 - A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis Phase 2
Recruiting NCT03075046 - Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial N/A